China’s State FDA Proposes Digital Monitoring For All Imported Drugs
This article was originally published in PharmAsia News
The regulation would require manufacturers of drugs imported to China to attach 20-digit barcodes, issued by China’s State FDA, to their wholesalers and individual packages. Imported drugs without such codes will be rejected after April 30, 2014.
You may also be interested in...
SHANGHAI - China's State FDA released its long-awaited good manufacturing practices guidelines for pharmaceutical products Feb. 12, which will begin to be implemented in all new drug manufacturing sites in March
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.